SNDX-5613
CAY-40758-25 25 mg
Data Sheet: 
SDS:
SDS:
CAS
2169919-21-3
Formulation
A solid
Purity
≥98%
MW
630,8
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
A derivative of VTP-50469; inhibits the growth of patient-derived AML cells expressing UBF-TDs when the cells are co-cultured with mesenchymal stem cells; reduces disease burden and improves survival when used alone at 50 mg/kg and, to a greater extent, when used in combination with GNE-781 in a MOLM-13 mouse xenograft model; reduces disease burden and increases survival in PDX mouse models in which tumor cells contain rearrangements in the gene encoding KMT2A or mutations in the gene encoding NPM1
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
